Substitution of Doxil in Ovarian Cancer? There Must Be a Better Way

By Brittany | February 28, 2012 | Category: Cancer, Ovarian cancer, Pharmacotherapy
Substitution of Doxil in Ovarian Cancer? There Must Be a Better Way
By Ralph Tarantino, PhD
Pharmaceutical Consultant and Principal, SteriTech Solutions, LLC
Middletown, NJ

The FDA’s most recent response to the anti-cancer drug shortage crisis may be a perfect example of “too little, too late.” What follows will not be a rant about offshore outsourcing or the regulatory climate in general. However, the FDA decision (See FDA’s Press Release regarding shortages of anti-cancer drugs here) to allow Sun Pharma’s version of Doxil (doxorubicin HCl liposome injection) into the United States to replace the approved Ben Venue product may be a dangerous one for patients with ovarian cancer.

[More]


A Woman’s Sexual Health: Ready for Prime Time?

By Brittany | February 21, 2012 | Category: Sexuality
A Woman’s Sexual Health: Ready for Prime Time?

 

By Michael L. Krychman, MDCM
Medical Director The Sexual Medicine Center, Executive Director Southern California Center of Sexual Health and Survivorship Medicine Newport Beach, CA, Faculty Member University of Southern California Los Angeles, CA.

As a health care professional I see that many women are now becoming more active in their own sexual satisfaction and discussing issues of sexual health concerns; however, it is remarkably amazing how different the media sees the difference between male and female sexuality. It is not uncommon to pick up a lay magazine or watch a prime time television show and see an advertisement for a male erectile medication. The media has essentially embraced male erectile dysfunction and even use the word erection. But when was the last time we saw an ad about vaginal dryness or female sexual pain or a woman’s loss of sexual interest?

[More]


"Take Two Prozac and Call Me in the Morning"

By Brittany | February 10, 2012 | Category: Depression, Mood disorders, Pharmacotherapy
"Take Two Prozac and Call Me in the Morning"
By Ralph Tarantino, PhD
Pharmaceutical Consultant and Principal, SteriTech Solutions, LLC
Middletown, NJ
 

A recent analysis of the CDC’s National Ambulatory Medical Care Surveys (Health Aff. 2011;30:1434) showed that 4 out of 5 prescribers of antidepressants are not psychiatrists. Alarmed? You should be.

White, female patients over the age of 50 with some form of health coverage are the usual recipients of this treatment. Frequently, they have other chronic illnesses, and for many no true diagnosis of depression exists. As a culture we have been bombarded with the warning that “depression is a serious medical condition”; it’s a warning that should be heeded. The costs of depression with regard to human life, the health care system, and the economy in general are enormous.

[More]


A Worrisome Cancer in Women—And It’s Not Breast

By Brittany | February 01, 2012 | Category: Cancer
A Worrisome Cancer in Women—And It’s Not Breast
By Barbara Gottlieb, MD, MPH
Associate Professor, Harvard Medical School; Associate Professor, Harvard School of Public Health; Brookside Community Health Center and Associate Physician, Brigham and Women's Hospital, Boston, MA

Although my patients have very diverse backgrounds (ie, in class, age, ethnicity, race, education, language, health literacy), they are quite similar in what they fear and what they don’t fear. For my female patients, breast cancer is at the top of the list. Somewhere beneath that is diabetes, then heart disease, stroke, and others that you would expect. I’m pretty sure that for most of my patients, lung cancer doesn’t even make it on the list.

[More]


Month List

RecentComments

Comment RSS